1. Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: report of two cases
   Ken-ichi Harada et al, 2011, Clinical and Experimental Nephrology CrossRef
2. Combined Immunotherapy with Low-dose IL-2 Plus IFN-  for Metastatic Renal Cell Carcinoma: Survival Benefit for Selected Patients with Lung Metastasis and Serum Sodium Level
   H. Akaza et al, 2011, Japanese Journal of Clinical Oncology CrossRef
3. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides
   Hidenori Kawashima et al, 2014, BJU International CrossRef
4. Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based on gene set enrichment analysis
   Haipeng Huang et al, 2014, International Urology and Nephrology CrossRef
5. Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
   Zofia Felicja Bielecka et al, 2014, Frontiers in Oncology CrossRef
6. Recent advances in the treatment of metastatic renal cell carcinoma
   Hideyuki Abe et al, 2013, International Journal of Urology CrossRef